Turkey's 'pandemic plan' prepared in 2019 seems to have helped it avoid a full-blown coronavirus catastrophe, former US diplomat Matthew Bryza says
against the pandemic was published in April 2019, which helped Ankara cope with the coronavirus pandemic.
Two days after the first case, the Turkish government shut all schools and four days later, all cafes, restaurants, bars and gyms were closed. In a further effort to control the contagion, weekend lockdowns were imposed in April and May, sometimes extended to four days."Unlike in Madrid or Lombardy or New York City, Turkey’s healthcare system was never overwhelmed by Covid-19 patients. And the world’s steepest coronavirus infection curve is now declining precipitously," he said.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Restaurant bookings data show U.S. economy is starting to revive after Covid closuresNew data on the pace of restaurant reservations show that the national decline in bookings is starting to slow.
続きを読む »
Four months in: A timeline of how COVID-19 has unfolded in the USIt's been more than four months since the CDC announced the first confirmed coronavirus case in the U.S. In that time, the coronavirus has claimed the lives of 100,000 Americans.
続きを読む »
COVID-19 Has Killed Close To 300 U.S. Health Care Workers, New Data From CDC ShowsMore than 60,000 health care workers have contracted the coronavirus, up from 9,000 in April. Workers say they face unnecessary risks because of ongoing shortages of protective gear like masks.
続きを読む »
Brazil Counts Almost Twice As Many Daily Covid-19 Deaths As The U.S.Brazil has reported nearly twice as many new Covid-19 deaths as the U.S. in the previous 24 hours Tuesday—a menacing marker as the country emerges as the world’s new epicenter for the virus
続きを読む »
Olivia Bowen lands US hosting gig but is disrupted but is disrupted by COVIDLove Island royalty Olivia is set for a major career shift, but the coronavirus crisis has thrown a spanner in the works
続きを読む »
Novartis to make U.S. researchers' COVID-19 gene therapy vaccine hopefulNovartis re-entered vaccine making on Thursday, inking a manufacturing deal with a U.S. team whose COVID-19 candidate relies on technology similar to that of the Swiss drugmaker's $2.1 million-per-patient gene therapy, Zolgensma.
続きを読む »